171 related articles for article (PubMed ID: 28806854)
1. Generation of Xeno-Free, cGMP-Compliant Patient-Specific iPSCs from Skin Biopsy.
Wiley LA; Anfinson KR; Cranston CM; Kaalberg EE; Collins MM; Mullins RF; Stone EM; Tucker BA
Curr Protoc Stem Cell Biol; 2017 Aug; 42():4A.12.1-4A.12.14. PubMed ID: 28806854
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
3. cGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindness.
Wiley LA; Burnight ER; DeLuca AP; Anfinson KR; Cranston CM; Kaalberg EE; Penticoff JA; Affatigato LM; Mullins RF; Stone EM; Tucker BA
Sci Rep; 2016 Jul; 6():30742. PubMed ID: 27471043
[TBL] [Abstract][Full Text] [Related]
4. cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications.
Baghbaderani BA; Tian X; Neo BH; Burkall A; Dimezzo T; Sierra G; Zeng X; Warren K; Kovarcik DP; Fellner T; Rao MS
Stem Cell Reports; 2015 Oct; 5(4):647-59. PubMed ID: 26411904
[TBL] [Abstract][Full Text] [Related]
5. Human-Induced Pluripotent Stem Cell Culture Methods Under cGMP Conditions.
Rivera T; Zhao Y; Ni Y; Wang J
Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e117. PubMed ID: 32649060
[TBL] [Abstract][Full Text] [Related]
6. Generation of a human iPSC line from a patient with retinitis pigmentosa caused by mutation in PRPF8 gene.
Lukovic D; Bolinches-Amorós A; Artero-Castro A; Pascual B; Carballo M; Hernan I; Erceg S
Stem Cell Res; 2017 May; 21():23-25. PubMed ID: 28677533
[TBL] [Abstract][Full Text] [Related]
7. A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells.
Lu HF; Chai C; Lim TC; Leong MF; Lim JK; Gao S; Lim KL; Wan AC
Biomaterials; 2014 Mar; 35(9):2816-26. PubMed ID: 24411336
[TBL] [Abstract][Full Text] [Related]
8. cGMP Generation of Human Induced Pluripotent Stem Cells with Messenger RNA.
Ni Y; Zhao Y; Warren L; Higginbotham J; Wang J
Curr Protoc Stem Cell Biol; 2016 Nov; 39(1):4A.6.1-4A.6.25. PubMed ID: 31816187
[TBL] [Abstract][Full Text] [Related]
9. Reprogramming of Human Fibroblasts with Non-integrating RNA Virus on Feeder-Free or Xeno-Free Conditions.
Lieu PT
Methods Mol Biol; 2015; 1330():47-54. PubMed ID: 26621588
[TBL] [Abstract][Full Text] [Related]
10. Induction of pluripotent stem cells by reprogramming human ocular fibroblasts under xeno-free conditions.
Xiong Y; Liu Y; Ge J
Arq Bras Oftalmol; 2018; 81(5):376-383. PubMed ID: 30208139
[TBL] [Abstract][Full Text] [Related]
11. Automating iPSC generation to enable autologous photoreceptor cell replacement therapy.
Bohrer LR; Stone NE; Mullin NK; Voigt AP; Anfinson KR; Fick JL; Luangphakdy V; Hittle B; Powell K; Muschler GF; Mullins RF; Stone EM; Tucker BA
J Transl Med; 2023 Feb; 21(1):161. PubMed ID: 36855199
[TBL] [Abstract][Full Text] [Related]
12. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q
Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165
[TBL] [Abstract][Full Text] [Related]
13. cGMP-Compliant Expansion of Human iPSC Cultures as Adherent Monolayers.
Parr AM; Walsh PJ; Truong V; Dutton JR
Methods Mol Biol; 2016; 1357():221-9. PubMed ID: 25863788
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast-like cells as an effective feeder for the cultivation and derivation of new lines of human induced pluripotent stem cells.
Novosadova EV; Manuilova ES; Arsenyeva EL; Grivennikov IA; Myasoedov NF
Dokl Biochem Biophys; 2016 Sep; 470(1):353-356. PubMed ID: 27817014
[TBL] [Abstract][Full Text] [Related]
15. Derivation of Neural Stem Cells from Mouse Induced Pluripotent Stem Cells.
Karanfil I; Bagci-Onder T
Methods Mol Biol; 2016; 1357():329-38. PubMed ID: 25863785
[TBL] [Abstract][Full Text] [Related]
16. Generation of induced pluripotent stem cell line (ZZUi0012-A) from a patient with Fahr's disease caused by a novel mutation in SLC20A2 gene.
Zhang Q; Li Z; Sun H; Zhang S; Zhang J; Wang Y; Fang H; Xu Y
Stem Cell Res; 2019 Mar; 35():101395. PubMed ID: 30776674
[TBL] [Abstract][Full Text] [Related]
17. Footprint- and xeno-free human iPSCs derived from urine cells using extracellular matrix-based culture conditions.
Lee KI; Kim HT; Hwang DY
Biomaterials; 2014 Sep; 35(29):8330-8. PubMed ID: 24994040
[TBL] [Abstract][Full Text] [Related]
18. Derivation of GMP-compliant integration-free hiPSCs using modified mRNAs.
Durruthy JD; Sebastiano V
Methods Mol Biol; 2015; 1283():31-42. PubMed ID: 25304205
[TBL] [Abstract][Full Text] [Related]
19. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
20. Purification of functional reprogramming factors in mammalian cell using FLAG -Tag.
Han MJ; Kim HR; O'Reilly C; Kim CH
Biochem Biophys Res Commun; 2017 Oct; 492(2):154-160. PubMed ID: 28802578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
